Busulfan (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Busulfan" in Italian language version.

refsWebsite

Global rank Italian rank

14nih.gov

4^th place

9^th place

3bloodjournal.org

low place

2oadoi.org

799^th place

22^nd place

2doi.org

2^nd place

7^th place

2bmj.com

1,226^th place

928^th place

1dottori.it

low place

1wiley.com

222^nd place

243^rd place

bloodjournal.org

Hehlmann R, Heimpel H, Hasford J, Kolb HJ, Pralle H, Hossfeld DK, Queisser W, Löffler H, Hochhaus A, Heinze B, Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group ^{[collegamento interrotto]}, in Blood, vol. 84, n. 12, 1994, pp. 4064-77, PMID 7994025. URL consultato il 4 febbraio 2018.
Hassan M, Ljungman P, Bolme P, Ringdén O, Syrůcková Z, Békàssy A, Starý J, Wallin I, Kållberg N, Busulfan bioavailability ^{[collegamento interrotto]}, in Blood, vol. 84, n. 7, 1994, pp. 2144-50, PMID 7919328. URL consultato il 4 febbraio 2018.
Ruiz Reyes G, Tamayo Perez R, Leukemia and pregnancy: observation of a case treated with busulfan (myleran) ^{[collegamento interrotto]}, in Blood, vol. 18, 1961, pp. 764-8, PMID 14495232. URL consultato il 4 febbraio 2018.

bmj.com

thorax.bmj.com

Littler WA, Busulphan lung: clinical features, in Thorax, vol. 25, n. 2, 1970, p. 257, PMC 472170, PMID 5442007. URL consultato il 4 febbraio 2018.
Hasleton PS, Busulphan lung: histopathology, in Thorax, vol. 25, n. 2, 1970, p. 257, PMC 472171, PMID 5442008. URL consultato il 4 febbraio 2018.

doi.org

dx.doi.org

Brisse H, Orbach D, Lassau N, Servois V, Doz F, Debray D, Helfre S, Hartmann O, Neuenschwander S, Portal vein thrombosis during antineoplastic chemotherapy in children: report of five cases and review of the literature, in Eur. J. Cancer, vol. 40, n. 18, 2004, pp. 2659-66, DOI:10.1016/j.ejca.2004.06.013, PMID 15571949.
Shah AJ, Successful pregnancy after busulfan/cytoxan conditioning regimen for AML, in J. Pediatr. Hematol. Oncol., vol. 33, n. 5, 2011, pp. e180–1, DOI:10.1097/MPH.0b013e31821b9ebe, PMID 21694553.

dottori.it

farmaci.dottori.it

Proprieta di Myleran 2 mg 100 compresse rivestite con film - Dottori.it ^{[collegamento interrotto]}, su farmaci.dottori.it. URL consultato il 9 maggio 2017.

nih.gov

ncbi.nlm.nih.gov

Brunstein CG, Mcglave PB, The biology and treatment of chronic myelogenous leukemia, in Oncology (Williston Park, N.Y.), vol. 15, n. 1, 2001, pp. 23–31; discussion 31–2, 35, PMID 11271979.
Hehlmann R, Heimpel H, Hasford J, Kolb HJ, Pralle H, Hossfeld DK, Queisser W, Löffler H, Hochhaus A, Heinze B, Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group ^{[collegamento interrotto]}, in Blood, vol. 84, n. 12, 1994, pp. 4064-77, PMID 7994025. URL consultato il 4 febbraio 2018.
Iwamoto T, Hiraku Y, Oikawa S, Mizutani H, Kojima M, Kawanishi S, DNA intrastrand cross-link at the 5'-GA-3' sequence formed by busulfan and its role in the cytotoxic effect, in Cancer Sci., vol. 95, n. 5, 2004, pp. 454-8, PMID 15132775. URL consultato il 4 febbraio 2018.
Hassan M, Ljungman P, Bolme P, Ringdén O, Syrůcková Z, Békàssy A, Starý J, Wallin I, Kållberg N, Busulfan bioavailability ^{[collegamento interrotto]}, in Blood, vol. 84, n. 7, 1994, pp. 2144-50, PMID 7919328. URL consultato il 4 febbraio 2018.
Blackburn EK, King GM, SwAN HT, Myleran in treatment of chronic myeloid leukaemia, in Br Med J, vol. 1, n. 4971, 1956, pp. 835-7, PMC 1979505, PMID 13304350.
Treatment of chronic granulocytic leukemia, in Can Med Assoc J, vol. 99, n. 3, 1968, pp. 129-30, PMC 1924385, PMID 4877613.
Hayhoe FG, Kok D, Medullary aplasia in chronic myeloid leukaemia during busulphan therapy, in Br Med J, vol. 2, n. 5059, 1957, pp. 1468-71, PMC 1962898, PMID 13489262.
Grigg A, Gibson R, Bardy P, Szer J, Acute portal vein thrombosis after autologous stem cell transplantation, in Bone Marrow Transplant., vol. 18, n. 5, 1996, pp. 949-53, PMID 8932850.
Brisse H, Orbach D, Lassau N, Servois V, Doz F, Debray D, Helfre S, Hartmann O, Neuenschwander S, Portal vein thrombosis during antineoplastic chemotherapy in children: report of five cases and review of the literature, in Eur. J. Cancer, vol. 40, n. 18, 2004, pp. 2659-66, DOI:10.1016/j.ejca.2004.06.013, PMID 15571949.
Littler WA, Busulphan lung: clinical features, in Thorax, vol. 25, n. 2, 1970, p. 257, PMC 472170, PMID 5442007. URL consultato il 4 febbraio 2018.
Hasleton PS, Busulphan lung: histopathology, in Thorax, vol. 25, n. 2, 1970, p. 257, PMC 472171, PMID 5442008. URL consultato il 4 febbraio 2018.
Littler WA, Ogilvie C, Lung function in patients receiving busulphan, in Br Med J, vol. 4, n. 5734, 1970, pp. 530-2, PMC 1820065, PMID 5274155.
Ruiz Reyes G, Tamayo Perez R, Leukemia and pregnancy: observation of a case treated with busulfan (myleran) ^{[collegamento interrotto]}, in Blood, vol. 18, 1961, pp. 764-8, PMID 14495232. URL consultato il 4 febbraio 2018.
Shah AJ, Successful pregnancy after busulfan/cytoxan conditioning regimen for AML, in J. Pediatr. Hematol. Oncol., vol. 33, n. 5, 2011, pp. e180–1, DOI:10.1097/MPH.0b013e31821b9ebe, PMID 21694553.

oadoi.org

Brisse H, Orbach D, Lassau N, Servois V, Doz F, Debray D, Helfre S, Hartmann O, Neuenschwander S, Portal vein thrombosis during antineoplastic chemotherapy in children: report of five cases and review of the literature, in Eur. J. Cancer, vol. 40, n. 18, 2004, pp. 2659-66, DOI:10.1016/j.ejca.2004.06.013, PMID 15571949.
Shah AJ, Successful pregnancy after busulfan/cytoxan conditioning regimen for AML, in J. Pediatr. Hematol. Oncol., vol. 33, n. 5, 2011, pp. e180–1, DOI:10.1097/MPH.0b013e31821b9ebe, PMID 21694553.

wiley.com

onlinelibrary.wiley.com

Iwamoto T, Hiraku Y, Oikawa S, Mizutani H, Kojima M, Kawanishi S, DNA intrastrand cross-link at the 5'-GA-3' sequence formed by busulfan and its role in the cytotoxic effect, in Cancer Sci., vol. 95, n. 5, 2004, pp. 454-8, PMID 15132775. URL consultato il 4 febbraio 2018.